Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Communications Biology|June 29, 2026
Nuclear RNA clusters are dynamic structural entities in Huntington's diseaseSandra Fienko, Iulia M Nita, Ignacio Munoz-Munoz, et al.Plos One|February 21, 2012
Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's diseaseLara Moumné, Ken Campbell, David Howland, et al.Nature Communications|September 29, 2018
Regulatory mechanisms of incomplete huntingtin mRNA splicingAndreas Neueder, Anaelle A Dumas, Agnesska C Benjamin, et al.Scientific Reports|March 22, 2021
Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's diseaseMarie Katrin Bondulich, Yilan Fan, Yeojin Song, et al.Journal of Huntington'S Disease|November 26, 2016
Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's DiseaseAlexander P Osmand, Terry Jo Bichell, Aaron B Bowman, et al.Neurobiology of Disease|June 22, 2005
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunctionRuben Smith, Asa Petersén, Gillian P Bates, et al.Plos One|December 4, 2009
Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's diseaseHilary Moffitt, Graham D McPhail, Ben Woodman, et al.Plos One|April 18, 2013
Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HDIvan Rattray, Edward Smith, Richard Gale, et al.RNA Biology|November 22, 2013
Aberrantly spliced HTT, a new player in Huntington's disease pathogenesisTheresa A Gipson, Andreas Neueder, Nancy S Wexler, et al.The Lancet. Neurology|October 16, 2015
Treating the whole body in Huntington's diseaseJeffrey B Carroll, Gillian P Bates, Joan Steffan, et al.Pageof 15